Craig Maria E, Jones Timothy W, Silink Martin, Ping Yeo Jing
Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
J Diabetes Complications. 2007 Sep-Oct;21(5):280-7. doi: 10.1016/j.jdiacomp.2006.04.005.
The incidence of type 1 diabetes is increasing in many parts of Asia, where resources may not enable targets for glycemic control to be achieved. The aims of this study were to describe glycemic control, diabetes care, and complications in youth with type 1 diabetes from the Western Pacific Region and to identify factors associated with glycemic control and hypoglycemia.
A cross-sectional clinic-based study on 2312 children and adolescents (aged <18 years; 45% males) from 96 pediatric diabetes centers in Australia, China, Hong Kong, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand was conducted. Clinical and management details were recorded, and finger-pricked blood samples were obtained for central glycated hemoglobin (HbA(1c)).
The median age of the patients was 12.5 years [interquartile range (IQR)=9.4-15.3 years]; diabetes duration, 4.4 years (IQR=2.5-7.2 years); and HbA(1c) level, 8.3% (IQR 7.4%-9.7%). Insulin treatment consisted of one or two daily injections in 61% of the patients (range=22%-90% by country), and home blood glucose monitoring (range=67%-100%) was practiced by 96%. HbA(1c) level was significantly associated with country, age, diabetes duration, sex, insulin dose per kilogram, insulin regimen, and frequency of home blood glucose measurement in multiple regression analysis. The incidence of severe hypoglycemia, defined as any episode requiring assistance in the previous 3 months, was 73 per 100 patient-years and was associated with country, male sex, higher HbA(1c) level, an insulin regimen with three or more injections, and more frequent home blood glucose testing. The incidence of diabetic ketoacidosis was 10 per 100 patient-years and was associated with country, higher HbA(1c) level, and higher insulin dose per kilogram.
There is marked variability in glycemic control, hypoglycemia, complication rates, and diabetes care among children from the Western Pacific Region. Most are not achieving adequate glycemic control, placing them at high risk of microvascular complications.
在亚洲许多地区,1型糖尿病的发病率正在上升,而当地资源可能无法实现血糖控制目标。本研究的目的是描述西太平洋地区1型糖尿病青少年的血糖控制、糖尿病护理及并发症情况,并确定与血糖控制和低血糖相关的因素。
对来自澳大利亚、中国、中国香港、印度尼西亚、日本、马来西亚、菲律宾、新加坡、韩国、中国台湾和泰国96家儿科糖尿病中心的2312名儿童和青少年(年龄<18岁;45%为男性)进行了一项基于诊所的横断面研究。记录临床和管理细节,并采集指尖血样以检测糖化血红蛋白(HbA1c)。
患者的中位年龄为12.5岁[四分位间距(IQR)=9.4 - 15.3岁];糖尿病病程为4.4年(IQR=2.5 - 7.2年);HbA1c水平为8.3%(IQR 7.4% - 9.7%)。61%的患者胰岛素治疗为每日注射1次或2次(各国范围为22% - 90%),96%的患者进行家庭血糖监测(范围为67% - 100%)。在多元回归分析中,HbA1c水平与国家、年龄、糖尿病病程、性别、每千克胰岛素剂量、胰岛素治疗方案及家庭血糖测量频率显著相关。严重低血糖的发生率(定义为过去3个月内任何需要协助的发作)为每100患者年73次,与国家、男性、较高的HbA1c水平、每日注射3次或更多次的胰岛素治疗方案及更频繁的家庭血糖检测相关。糖尿病酮症酸中毒的发生率为每100患者年10次,与国家、较高的HbA1c水平及每千克较高的胰岛素剂量相关。
西太平洋地区儿童在血糖控制、低血糖、并发症发生率及糖尿病护理方面存在显著差异。大多数儿童未实现充分的血糖控制,使其面临微血管并发症的高风险。